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Objectives: Endovascular aortic repair has revolution-
ized the management of blunt aortic trauma. However,
debate continues about the extent of injury requiring endo-
vascular repair, particularly with regard to minimal aortic
injury. Therefore, we conducted a retrospective observa-
tional analysis of our experience with these patients.
Methods: Weretrospectively reviewedall blunt traumatic
aortic injuries at an academic Level I trauma center over a ten-
year period (2001-2010). Images were reviewed by a radiolo-
gist and graded according to SVS guidelines (Grade I-IV).
Demographics, injury severity, and outcomes were recorded.
Results: We identiﬁed214patientswithblunt injuries to
the thoracic or abdominal aorta. 115 were deemed operative
injuries at presentation and were excluded from analysis. The
remaining 99 were observed. On presentation, 54 had
minimal (Grade I or II) injury. Of these, 43 had follow-up
imaging at a mean of 102 days postinjury and constitute
our study cohort. Mean age was 39 years and mean length
of stay was 16 days. Forty-one patients (95%) had Grade I
injury (intimal ﬂap) and two patients had Grade II injury
(medial hematoma). Forty (93%) were thoracic aortic injuries
and the remaining were abdominal. On follow-up imaging,
23 of 43 (54%) had complete resolution of injury, 18 (42%)
had no change in aortic injury, and two (5%) had progression
(enlargement) of injury. Of the 2 patients with progression,
one progressed fromGrade I to Grade II and one progressed
from Grade I to Grade III (pseudoaneurysm). Mean time to
progression was 16 days. Neither of the patients with injury
progression required operative intervention. No patients
were operated on or died from a grade I or II aortic injury.
Conclusions: Injury progression in Grade I-II blunt
aortic injury is rare (w5%) and did not cause death in our
study cohort. Since progression to Grade III injury is
possible, follow-up with repeat aortic imaging is reasonable.
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Objectives: No consensus exists for duplex ultrasound
criteria in diagnosing signiﬁcant common carotid artery
(CCA) stenosis. In general, peak systolic velocity (PSV)
>150 cm/s with poststenotic turbulence indicates
a stenosis >50%. The purpose of our study is to correlateCCA duplex velocities with angiographic ﬁndings of signif-
icant CCA stenosis >60%.
Methods: We reviewed the carotid duplex records
from 2008-2011 looking for patients with isolated CCA
stenosis and no ipsilateral internal or contralateral carotid
artery disease who either received a carotid angiogram
(CA) or a computed tomographic angiography (CTA).
We identiﬁed 25 patients who had CCA stenosis >60%.
We also randomly selected 74 controls with no known
CCA stenosis. We performed receiver operating character-
istics (ROC) analysis to correlate PSV and end-diastolic
velocity (EDV) with angiographic stenosis >60%. The
degree of stenosis was determined by measuring the
luminal stenosis in comparison to the proximal normal
CCA diameter just below the lesion.
Results: Most patients had a carotid angiogram (17/
25), four had a CTA only and four had both. Eighteen
patients had history of a radiated neck. Eighteen patients
were treated with a stent, three with endarterectomy and
four with medical management. The CCA PSV >
250 cm/sec had a sensitivity of 100% (81.5%-100%) and
a speciﬁcity of 98.7% (92.0%-99.9%), The CCA EDV >
60 cm/sec had a sensitivity of 95.5% (75.1%-99.8%) and
speciﬁcity of 100% (94.1%-100%). The presence of both
PSV <250 and EDV <60 cm/sec had a 100% negative
predictive value, and the presence of both PSV $250 and
EDV $60 had 100% positive predictive value.
Conclusions: Establishing CCA duplex criteria to
screen patients with signiﬁcant stenosis is crucial to identify
those that will need further imaging modality or treatment.
In our lab, CCA PSV > 250cm/sec and EDV > 60cm/sec
are thresholds that can be used to identify signiﬁcant
(>60%) CCA stenosis with a high degree of accuracy.
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Objectives: Arteriovenous grafts (AVG) are used in
hemodialysis patients when autogenous ﬁstulas are not
feasible. The optimal location (forearm vs upper arm)
and conﬁguration (loop vs straight) of AVG is not known.
To evaluate relationships between AVG location or conﬁg-
uration and patency we conducted subgroup analyses
among participants enrolled in a randomized, placebo-
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Methods: Participants in the Dialysis Access Consor-
tium trial with upper extremity prosthetic grafts of the
brachial artery were studied. Multivariable analyses adjust-
ing for treatment group, center, gender, race, BMI, dia-
betes, current dialysis, and prior access or catheter were
performed to compare outcomes of forearm (fAVG) and
upper arm (uAVG) grafts including loss of primary unas-
sisted patency (LPUP) and cumulative primary graft failure
(CGF). Subgroup analyses of graft conﬁguration and
outﬂow vein used were conducted.
Results: Of the 522 participants with an upper
extremity brachial artery graft, 269 had fAVG and 253 had
uAVG. Participants with fAVG were less often male (33%
vs 43%; P ¼ .03), black (62% vs 77%; P < .001), dialysis-
dependent at time of surgery (20% vs 36%; P < .001), and
had a higher mean BMI (32 vs 29; P < .001) compared to
those with uAVG. There was no difference in LPUP (69%
vs 78%; P ¼ .22) or CGF (32% vs 36%; P ¼ .53) between
fAVG and uAVG at 1 year follow-up. Multivariable adjust-
ment did not change the statistical signiﬁcance of the associ-
ation between AVG location and either LPUP (HR, 1.26;
95% CI, 0.98, 1.62; P ¼ .07) or CGF (HR, 1.09; 95% CI,
0.80, 1.49; P ¼ .58). LPUP did not differ signiﬁcantly
between fAVG and uAVG among subgroups based on
AVGconﬁguration (P¼ .23) or outﬂow vein used (P¼ .53).
Conclusions: Patency of fAVG and uAVG was similar
despite the larger caliber veins often encountered in the
upper arm. Therefore, to preserve a maximal number of
access sites, the forearm location should be considered ﬁrst
before resorting to an upper arm graft.
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Background: Vascular surgeons are sometimes faced
with central vein occlusions and other situations where
upper limb ﬁstulas are not viable. In the lower limb pros-
thetic grafts have been the mainstay conduit for dialysis
access with high rates of occlusion and infection. Some
authors have published data on the use of the femoral
superﬁcial vein however this is a long complex procedure
with signiﬁcant disruption of the lower limb venous return.
The greater saphenous vein (GSV) has proved previously to
be a poor conduit due to its resistance to dilatation and
only few reports have mentioned its effective use in dialysis.
The technique exhibited in this video results in
a doubled diameter of the GSV allowing easy puncture
and effective dialysis. It has all the advantages of anautologous conduit without the morbidity associated
with the superﬁcial femoral vein graft.
We also believe that this technique can be used in other
locations such as the upper limb in selected patients not
candidates for prosthetic grafts.
Technical Description: After harvesting the required
length of the GSV, it is opened longitudinally upto approx-
imately 5 cm from the sapheno-femoral junction (but not
sectioned vertically to avoid the requirement for a veno-
venous anastomosis). The GSV is freed from all valves
and then folded in two creating one anterior and one
posterior vein panel.
The lateral edges of the panels are sutured together,
and the medial edges together effectively creating
a cylinder, whilst doubling the initial GSV diameter. After
venous testing the vein is tunnelled subcutaneously and
down to the superﬁcial femoral artery (SFA). The size of
the anastomosis is tailored to avoid lower limb steal
syndrome. The vein is anastomosed to the SFA.
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Objectives: Retrievable IVC ﬁlters are appealing
because they are designed for either retrieval or long
term use. However, their long-term safety compared to
permanent ﬁlters is largely unknown. This study was under-
taken to compare complication rates and types associated
with retrievable and permanent ﬁlters.
Methods: A retrospective review identiﬁed 1231 IVC
ﬁlters (447 retrievable, 784 permanent) placed in 1227
patients from 2005-2010. Patients with retrievable ﬁlters
removed electively were excluded, yielding 382 patients
(group A) in whom retrievable ﬁlters were left in place.
These patients were compared to those with permanent
ﬁlters (group B) with respect to demographics, comorbid-
ities, survival, and complication rate and type. Differences
in patient characteristics were tested with c2, Fisher exact,
and Wilcox rank-sum tests. Logistic regression was used to
identify predictors of complications.
Results: Group A patients were younger than those in
group B (mean age, 64 vs 75; P < .0001). Group A had
signiﬁcantly more complications than group B (9.7% vs
1.9%; P < .0001) after mean follow up of 20 months
(range 0-86 mo). Furthermore, retrievable ﬁlter type was
a signiﬁcant predictor of complications in a multivariate
model (odds ratio, 5.4; P < .0001). Filter complications
were categorized as thrombotic, device related, or systemic.
While the most common complication type with retriev-
able ﬁlters was device related (52%) and with permanent
ﬁlters was thrombotic (63%), both thrombotic and device
related complications occurred more frequently in group
